Group One Trading’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.1K Buy
+7,373
New +$93.1K ﹤0.01% 5048
2025
Q4
Sell
-12,228
Closed -$227K 8233
2025
Q3
$266K Buy
+12,228
New +$144K ﹤0.01% 4363
2024
Q1
Sell
-6,959
Closed -$48.6K 7147
2023
Q4
$47.3K Buy
6,959
+5,897
+555% +$33.4K ﹤0.01% 5103
2023
Q3
$5.32K Buy
+1,062
New +$6.32K ﹤0.01% 6670
2022
Q2
Sell
-3,077
Closed -$31.4K 7893
2022
Q1
$32K Sell
3,077
-8,178
-73% -$74.4K ﹤0.01% 6426
2021
Q4
$126K Buy
11,255
+132
+1% +$1.98K ﹤0.01% 5511
2021
Q3
$197K Sell
11,123
-2,515
-18% -$47.2K ﹤0.01% 5187
2021
Q2
$260K Buy
13,638
+13,589
+27,733% +$263K ﹤0.01% 4938
2021
Q1
$1K Buy
+49
New +$1.05K ﹤0.01% 7447

Other funds holding CLPT

Group One Trading's CLPT Position: Q1 2026 in Review

Group One Trading opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 7,373 shares worth $67.1K. The stake represents ﹤0.01% of the portfolio and ranks #5048 among its holdings. This is a return to the name: Group One Trading previously reported a position in CLPT as recently as Q3 2025.

Group One Trading first reported a position in CLPT in Q1 2021 and has held it in 9 quarters since. The position peaked at $266K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Group One Trading held 7,373 shares of ClearPoint Neuro worth $67.1K as of Q1 2026.
  • ClearPoint Neuro was a new Group One Trading position in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5048 holding.
  • Group One Trading first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 9 quarters since.
  • Group One Trading's ClearPoint Neuro position peaked at $266K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.